Answers are grounded in this paper and cite their sources.
Peripheral stem cell (PSC) harvests from patients with non-Hodgkin's lymphoma (NHL) and breast cancer are less likely to be contaminated with occult tumor cells detected by culture techniques, than are bone marrow harvests. Clinically, NHL patients transplanted with such PSC harvests had a better outcome than recipients of bone marrow harvests.
No takes yet. Share an insight, caveat, or question.
Sharp et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: